Executive Bio
Mr. Kevin D. Cordell has been President of US at Wright Medical Group N.V. since June 2016 and served as its President of Lower Extremities and Biologics since October 14, 2015 until June 2016. Mr. Cordell has been President of U.S. Extremities at Wright Medical Technology, Inc. since September 2014. He served as Vice President of US Sales at B???RRX Medical, Inc. Mr. Cordell served as the President of U.S. Extremities at Wright Medical Group Inc. since September 29, 2014 until October 2015. Prior to joining Wright Medical, Mr. Cordell served as Vice President of Sales for the GI Solutions business at Covidien, a leading global healthcare products company, from May 2012 to September 2014. While at Covidien, he also served as Vice President of Sales & Global Marketing for its Peripheral Vascular business from July 2010 to May 2012. He joined Covidien in July 2010 through the acquisition of ev3 Inc., where he served as Vice President of U.S. Sales from January 2009 to July 2010. Prior to ev3, Mr. Cordell served as Senior Vice President of Global Sales at Foxhollow Technologies Inc., since February 28, 2007. Mr. Cordell leads FoxHollow's worldwide sales organization, focusing and executing on corporate strategies for the growth and expansion of FoxHollow's current product lines as well as the expansion of the Foxhollow's product portfolio with the integration of potential future product acquisitions. Mr. Cordell has over 12 years of experience in the pharmaceutical, biotech and medical device industries. Mr. Cordell served as Vice President of Sales at Cordis Cardiology, a Johnson & Johnson Company specializing in medical devices for vascular intervention., since 2005. Mr. Cordell joined Cordis Cardiology in 2003 as Executive Sales Director and served as a board member of Cordis Cardiology. He held various sales and marketing positions with Centocor, Inc., a subsidiary of Johnson & Johnson, focusing on the development of biomedicines to treat immune disorders. He started his sales career in 1993 with Boehringer Mannheim Corporation, a wholly-owned subsidiary of the Roche Corporation. He received his bachelor's degree in finance from the University of Oklahoma.